tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATR Stock Latest News

AptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
RatingsAptarGroup’s Strategic Shift to Pharma Drives Buy Rating Amid Profitability Gains
2d ago
ATR
AptarGroup price target lowered to $152 from $153 at Wells Fargo
PremiumThe Fly
AptarGroup price target lowered to $152 from $153 at Wells Fargo
3d ago
ATR
AptarGroup: Balancing Long-Term Potential with Short-Term Challenges – Hold Rating
PremiumRatings
AptarGroup: Balancing Long-Term Potential with Short-Term Challenges – Hold Rating
3d ago
ATR
AptarGroup raises quarterly dividend ~7% to 48c per share
PremiumThe Fly
AptarGroup raises quarterly dividend ~7% to 48c per share
4d ago
ATR
AptarGroup initiated with an Overweight at KeyBanc
PremiumThe Fly
AptarGroup initiated with an Overweight at KeyBanc
9d ago
ATR
AptarGroup: Strong Performance and Growth Potential Amid Temporary Challenges
PremiumRatingsAptarGroup: Strong Performance and Growth Potential Amid Temporary Challenges
1M ago
ATR
AptarGroup price target lowered to $172 from $182 at Raymond James
Premium
The Fly
AptarGroup price target lowered to $172 from $182 at Raymond James
1M ago
ATR
AptarGroup price target lowered to $153 from $173 at Wells Fargo
Premium
The Fly
AptarGroup price target lowered to $153 from $173 at Wells Fargo
1M ago
ATR
AptarGroup Reports Strong Q2 2025 Results
PremiumCompany Announcements
AptarGroup Reports Strong Q2 2025 Results
1M ago
ATR
AptarGroup Earnings Call: Pharma and Closures Shine
PremiumCompany Announcements
AptarGroup Earnings Call: Pharma and Closures Shine
1M ago
ATR
AptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
PremiumRatings
AptarGroup’s Consistent Financial Strength and Pharma Segment Growth Drive Buy Rating
1M ago
ATR
AptarGroup reports Q2 EPS $1.67, consensus $1.59
PremiumThe Fly
AptarGroup reports Q2 EPS $1.67, consensus $1.59
1M ago
ATR
AptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
PremiumThe FlyAptarGroup sees Q3 EPS $1.53-$1.61, consensus $1.65
1M ago
ATR
Is ATR a Buy, Before Earnings?
Premium
Pre-Earnings
Is ATR a Buy, Before Earnings?
2M ago
ATR
AptarGroup price target raised to $173 from $170 at Wells Fargo
Premium
The Fly
AptarGroup price target raised to $173 from $170 at Wells Fargo
2M ago
ATR
AptarGroup acquires Mod3 Pharma’s clinical trial manufacturing capabilities
PremiumThe Fly
AptarGroup acquires Mod3 Pharma’s clinical trial manufacturing capabilities
2M ago
ATR
SWKH
AptarGroup debuts dual-active technology to control moisture, oxygen
PremiumThe Fly
AptarGroup debuts dual-active technology to control moisture, oxygen
2M ago
ATR
AptarGroup price target raised to $170 from $162 at Wells Fargo
PremiumThe Fly
AptarGroup price target raised to $170 from $162 at Wells Fargo
4M ago
ATR
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
PremiumRatings
AptarGroup’s Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
4M ago
ATR
AptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
PremiumCompany AnnouncementsAptarGroup’s Q1 2025 Results: Sales Dip, Pharma Grows
4M ago
ATR
AptarGroup’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
AptarGroup’s Earnings Call: Growth Amid Challenges
4M ago
ATR
AptarGroup’s Mixed Segment Performance and Economic Pressures Lead to Hold Rating
Premium
Ratings
AptarGroup’s Mixed Segment Performance and Economic Pressures Lead to Hold Rating
4M ago
ATR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >